NCT05737121: Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
- State
- Under way
- Phase
- Phase 2
- People
- 120 planned
- Started
- 22 May 2023
- Primary completion
- Jun 2026
- Arms
- Lidocaine
- Results
- None posted
- 21 Feb 2023: Trial registered
- 22 May 2023: Trial started